These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18176620)

  • 1. Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors.
    Marachelian A; Butturini A; Finlay J
    Bone Marrow Transplant; 2008 Jan; 41(2):167-72. PubMed ID: 18176620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
    Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
    Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of myeloablative chemotherapy with autologous hematopoietic cell rescue in central nervous system germ cell tumors.
    Bouffet E
    Pediatr Blood Cancer; 2010 Apr; 54(4):644-6. PubMed ID: 20146220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.
    Gilheeney SW; Khakoo Y; Souweidane M; Wolden S; Boulad F; Dunkel IJ
    Pediatr Blood Cancer; 2010 Apr; 54(4):591-5. PubMed ID: 19998470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
    Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H; Wolfe L; Kretschmar C
    Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of high-dose chemotherapy in CNS tumors.
    Butturini A; Frappaz D
    Pediatr Blood Cancer; 2010 Apr; 54(4):652-3. PubMed ID: 20146215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
    Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
    Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Fangusaro JR; Jubran RF; Allen J; Gardner S; Dunkel IJ; Rosenblum M; Atlas MP; Gonzalez-Gomez I; Miller D; Finlay JL
    Pediatr Blood Cancer; 2008 Mar; 50(3):715-7. PubMed ID: 17009232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of stem cell transplant for brain tumors.
    Gardner SL
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():28-32. PubMed ID: 15125703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
    Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who should receive myeloablative therapy for diffuse large B-cell lymphoma?
    Wannesson L; Zucca E
    Nat Clin Pract Oncol; 2008 Aug; 5(8):442-3. PubMed ID: 18607392
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary central nervous system lymphoma: recent progress, many remaining questions.
    Swinnen LJ
    Curr Opin Oncol; 2009 Sep; 21(5):393-6. PubMed ID: 19593137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose therapy and autologous hematopoietic stem cell transplantation in poor risk solid tumors of childhood.
    Dallorso S; Manzitti C; Morreale G; Faraci M
    Haematologica; 2000 Nov; 85(11 Suppl):66-70. PubMed ID: 11268328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
    Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S
    Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.